Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsInteractions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart StudyMetabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study.Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking IntensityEstimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.Measurement of smoking behavior: Comparison of self-reports, returned cigarette butts, and toxicant levels.A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers.Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measuresUtility and cutoff value of hair nicotine as a biomarker of long-term tobacco smoke exposure, compared to salivary cotinineRelationship between smoking reduction and cessation among light smokers.How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference.Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.Nicotine dependence phenotype, time to first cigarette, and risk of head and neck cancer.Nicotine dependence phenotype and lung cancer risk.Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Self-reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer.Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers.Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokersEffects of high dose transdermal nicotine replacement in cigarette smokersTobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smokeSwitching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers.Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokersSmokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.Comparison of Puff Volume With Cigarettes per Day in Predicting Nicotine Uptake Among Daily Smokers.Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.Validation of biomarkers for the study of environmental carcinogens: a review.Transdisciplinary Tobacco Use Research Centers: research achievements and future implications.Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.Utility and relationships of biomarkers of smoking in African-American light smokers.Relighting behaviour among cigarette smokers seeking treatment: implications for tobacco treatment and policyA review of the analysis of tobacco-specific nitrosamines in biological matrices.Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample.Health impact of smoking and smoking cessation strategies: current evidence.Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis.
P2860
Q26766294-414123B2-8625-4CDD-8665-23493CFAAC1EQ28244928-57D2E888-612E-4DA5-94BE-BE52E8AF9B9BQ33389830-26812592-238B-4061-8F5E-77250B9CC96DQ33499895-802FD809-A236-46D6-BD22-7FA28E524423Q33828249-F2197CF5-2492-4D48-9470-A65EBBB37C1DQ33839242-5F46E045-8212-40AD-8093-AB85625B8BFDQ34047090-233C2520-83CB-499E-A663-764811ADC9B0Q34049784-6B4FB4CE-4B02-4EDA-BA92-2B2FE8C2D3F2Q34057934-9E7BC862-9050-4AFC-94D0-2C2F31AF119CQ34086169-A08CACE0-803F-48FF-ADA2-EBEB40BC693CQ34166347-EC294A60-2560-4A64-8475-45888DE02AEFQ34396143-84DCC5DF-27E4-4A08-8C59-865C7A3399C5Q34425646-D51D1BF1-2A68-4582-88C2-EDF7D42C9DD0Q34556938-02892584-0E59-40DF-AA01-32AF54478B54Q35175672-41568D71-EF98-49DA-B5B2-928C8E4FF910Q35200071-62FAA1DB-9477-4ABF-853B-028D93F54157Q35541682-36B67298-37D0-4CF9-8AFF-846F4435632AQ35541742-6FDE7680-C5B5-423D-B97C-70E910F3BE07Q35638655-E2E5416D-9577-4F8B-AEE3-DAECEC7D80B0Q35883271-4A1C4E0F-5D1F-4355-84DD-E00B1C123FA4Q35899013-3CAEF5D2-5D40-424E-819C-EF92180ED09BQ35990500-C7CAD190-1F2F-42BC-9521-55244971460BQ36116552-8A1F92D7-85E0-4F1B-828E-6556795FB348Q36471952-07E4EE98-5F81-4424-AB0E-D7BDB0DA41B0Q36482371-B82D7CEF-7C20-4091-9F68-925A03966DADQ36863232-66940432-D0CF-44FF-859C-C7DAEAB3C1ADQ36891021-CF404C8F-BAA4-4EBC-9C10-C8982FC03807Q36983085-8515C6A4-5FC8-461C-8B65-97579FA2D7E1Q37056893-91001BCA-A2A3-47A7-89D0-02277E3027F9Q37149026-44EB1D2D-4D65-40B0-B734-DB7E23EFB027Q37315784-1518259E-D89C-464D-B336-63D62A4FA3B2Q37353353-2F95BCA0-10F9-4529-9B93-060B34C81A5AQ37395563-82A7895E-23C3-4DA3-819A-48EC8C8B1E14Q37406432-AC30D073-BC7F-4019-BC86-93F66564A92EQ37470700-85FD4D03-1466-427C-99F5-7A82192385A7Q37610285-B791008D-1E3F-4C6D-BE91-91EB02206AEAQ37704412-ADE71359-41D8-4A16-955B-6C0AC82321A7Q37705535-7411ACD4-1B12-4C28-BC78-537961DE3426Q38033048-3696E66F-71E5-4DC0-816C-1AC6BCB12481Q38797685-53A4ADB7-69E3-4E10-BD80-A463B82C7E37
P2860
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@en
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@nl
type
label
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@en
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@nl
prefLabel
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@en
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@nl
P2093
P1476
Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
@en
P2093
Anne M Joseph
Dorothy K Hatsukami
Shaomei Han
Sharon E Murphy
Steven G Carmella
P304
P356
10.1158/1055-9965.EPI-04-0768
P577
2005-12-01T00:00:00Z